Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
60 results (top 60)
- 2상모집 예정· Relapsed / Refractory Multiple Myeloma재발성 또는 불응성 다발성 골수종에서 베란타마브 마포도틴의 저용량 대 표준용량 비교
Comparing Lower Versus Standard Doses of Belantamab Mafodotin With Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma.
협력: GSK
- 2상모집 중· Liver Diseases, Alcoholic에피모스페르민 알파의 알코올 관련 간질환 대상 위약 대비 안전성 및 유효성 연구
A Study to Investigate the Safety and Efficacy of Efimosfermin Alfa Compared With Placebo in Adult Participants With Alcohol-related Liver Disease (ALD)
리드: GSK
- 2상모집 예정· Cardiovascular Disease심혈관 위험 성인에서 보조제 첨가 대상포진/RSV 백신의 관상동맥 플라크 진행 영향 연구
A Study Exploring the Effect of Adjuvanted RZV or RSVPreF3 Vaccines on Coronary Plaque Progression in Adults >=50 Years of Age at Risk for Cardiovascular Events
리드: GSK
- 2상모집 중· Gastrointestinal Neoplasms이매티닙, 수니티닙, 레고라페닙 및 피미테스피브 후 전이성 및/또는 절제 불가능한 위장관기질종양 환자에서의 벨자티닙 연구
A Study of Velzatinib in Participants With Metastatic and/or Unresectable GIST After Imatinib, Sunitinib, Regorafenib, and Pimitespib
리드: GSK
- 2상모집 예정· Multiple Myeloma재발성/불응성 다발성 골수종 환자에서 벨란타맙 마포도틴, 보르테조밉 및 덱사메타손의 대체 및 승인된 용량 요법에 관한 연구
Study of Alternative and Approved Dosing Regimens of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Participants With Relapsed/Refractory Multiple Myeloma
리드: GSK
- 2상모집 예정· Malaria, Falciparum단순 열대열원충 말라리아 성인 환자에서 새로운 항말라리아 피롤리디나마이드의 2a상 연구
A Phase 2A Study of a Novel Antimalarial Pyrrolidinamide in Adult Patients With Uncomplicated P. Falciparum Malaria
리드: GSK
- 2상모집 중· Amyloidosis새로 진단된 경쇄 아밀로이드증 환자에서 벨란타맙 마포도틴 병용 요법의 효능 및 안전성
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
리드: GSK
- 2상모집 중· Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma재발/전이성 두경부 편평세포암종에서 반응 및 내성 메커니즘 규명을 위한 다중오믹스 바이오마커 평가
A Comprehensive Multiomic Biomarker Evaluation Across Two Single-arm Cohorts to Elucidate Mechanisms of Response and Resistance in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)
협력: GSK
- 2상모집 중· Multiple Myeloma재발/불응성 다발성 골수종 환자에서 벨란타맙 마포도틴과 표준 치료 병용의 유효성 및 안전성 평가
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
리드: GSK
- 2상모집 중· Irritable Bowel Syndrome과민성 대장증후군 설사형(IBS-D) 및 혼합형(IBS-M) 성인에서 위약과 비교한 Camlipixant의 복부 증상 조사
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
리드: GSK
- 2상모집 중· Salmonella Infections영아에서 침습성 비장티푸스 살모넬라 질환 및 장티푸스에 대한 GVGH iNTS-TCV 백신의 안전성, 반응원성 및 면역 반응 평가
A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants
리드: GSK
- 2상모집 중· Kidney Transplant Rejection고감작 이식 환자에서 기억 B 세포 HLA 특이성 프로파일 개선을 통한 제외 대상 지원을 위한 Belimumab 연구
Belimumab to Mobilise Memory B-cells From Secondary Lymhoid Organs to Improve Memory B-cell HLA-specificity Profiling to Support Delisting for Transplant Access in Highly-sensitized
협력: GSK
- 2상모집 예정· Locally Advanced Rectal Cancer (LARC)XELOX Plus DoSTARlimab Versus XELOX Alone as Consolidation Treatment After Standard Chemoradiation in pMMR/MSS or MSI-Low Locally Advanced Rectal Cancer (LARC) Patients
협력: GSK
- 2상모집 예정· DiarrhoeaLong-Term Immunogenicity of the altSonflex1-2-3 Shigella Vaccine in African Children
리드: GSK
- 2상모집 중· Respiratory Syncytial Virus (RSV)Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons
협력: GSK
- 2상모집 중· BronchiectasisA Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
리드: GSK
- 2상모집 예정· MMRd/MSI-H Stage II-III Endometrial CancerClinical Trial to Assess the Efficacy of Dostarlimab as Neoadjuvant Therapy in Patients With MMRd/MSI-H Stage II-III Endometrial Cancer
협력: GSK
- 2상모집 예정· Endometrial CancerpReOperative Dostarlimab and Novel Therapies in EndOmetrial Cancer
협력: GSK
- 2상모집 중· Alzheimer's DiseaseOpen-label Extension Study in Participants With Early Alzheimer's Disease
리드: GSK
- 2상모집 중단 (진행 중)· Respiratory Syncytial Virus InfectionsA Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant
리드: GSK
- 2상모집 중· Myelodysplastic SyndromesA Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
리드: GSK
- 2상모집 중· Pancreatic Adenocarcinoma MetastaticMaintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy
협력: BMS, GSK
- 2상모집 중· Metabolic Dysfunction-Associated SteatohepatitisA Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
리드: GSK
- 2상모집 중· Primary MyelofibrosisStudy of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
리드: GSK
- 2상모집 중· Pancreas NeoplasmsDOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer
협력: GSK
- 2상모집 중단 (진행 중)· Chronic Hepatitis B Virus InfectionA Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)
리드: GSK
- 2상모집 중단 (진행 중)· Neoplasms, RectalA Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China
리드: GSK
- 2상모집 중단 (진행 중)· Plasma Cell MyelomaBelantamab Mafodotin and Lenalidomide for the Treatment of Multiple Myeloma in Patients With Minimal Residual Disease Positive After Stem Cell Transplant
협력: GSK
- 2상모집 중· Endometrial Cancer Stage ISATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)
협력: GSK
- 2상모집 중· Pancreatic AdenocarcinomaDostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
협력: GSK
- 2상모집 중· Relapsed CancerIsatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma
협력: GSK, 사노피
- 2상모집 중· Pulmonary TuberculosisPlatform Assessing Regimens and Durations In a Global Multisite Consortium for TB
협력: GSK, 얀센(J&J)
- 2상모집 중· SCLC,Extensive StageNiraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC
협력: GSK
- 2상조기 종료· Alzheimer's DiseaseEfficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease
리드: GSK
- 2상모집 중· Multiple MyelomaStudy of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma
협력: 암젠, GSK
- 2상모집 중단 (진행 중)· Neoplasms, RectalA Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer
리드: GSK
- 2상모집 중단 (진행 중)· Nonalcoholic Fatty Liver DiseasePhase 2b Study of GSK4532990 in Adults With NASH
리드: GSK
- 2상모집 중· Penile CarcinomaStudy of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma
협력: GSK
- 2상모집 중단 (진행 중)· Lung Cancer, Non-Small CellA Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer
리드: GSK
- 2상모집 중단 (진행 중)· Sarcoma,Soft TissueA Study of Niraparib in People With Soft Tissue Sarcoma Who Have Changes in Their Tumor DNA
협력: GSK
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.